
HIMS Stock Forecast & Price Target
HIMS Analyst Ratings
Bulls say
Hims & Hers Health Inc is experiencing significant growth, highlighted by a 70% year-over-year subscriber increase in Q4, suggesting strong demand for its telehealth services across various specialties, including weight loss and sexual health. The company's international portfolio and strategic partnerships, such as access to potential new weight loss drugs, are expected to contribute positively to future revenue growth, with adjustments anticipated to enhance margins and performance. Additionally, Hims & Hers is diversifying its offerings, reducing concentration risk by not solely relying on specific market narratives, thus positioning itself favorably for sustained revenue normalization in alignment with subscriber growth trends.
Bears say
Hims & Hers Health Inc. is facing a negative outlook primarily due to significantly slowing revenue growth, as evidenced by its disappointing 4Q:25 earnings results and weak guidance for 1Q:26. The company has reduced its full-year 2026 revenue estimates, now expected at $2.7 billion to $2.9 billion, compared to prior expectations, indicating a lack of momentum. Additionally, the increased legal and regulatory risks further compound concerns about the company's financial stability and future performance.
This aggregate rating is based on analysts' research of Hims & Hers Health and is not a guaranteed prediction by Public.com or investment advice.
HIMS Analyst Forecast & Price Prediction
Start investing in HIMS
Order type
Buy in
Order amount
Est. shares
0 shares